Impact of Breast Milk on the Infectivity and Transmission of Different Viruses "BREASTMILKVIR"

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorInstitut Pasteur

About this trial

Exclusive breastfeeding during the first six months of life and continued breastfeeding for at least 24 months constitute the optimal feeding method for infants and young children.

However, breast milk and breastfeeding can be significant pathways for the transmission of certain viruses.

The objective of this study is to examine the influence of human breast milk and its composition on viral infectivity and viral transmission of the HTLV-1 virus and arboviruses such as Zika virus, yellow fever, dengue, and tick-borne encephalitis.

Eligibility criteria

Qualifiers

Age > 18 years

Female gender

Lactarium Ile-de-France donors

Subjects covered by a Social Security scheme, excluding State Medical Aid

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Collection breast milk

Treatment groups

75 Participants
are divided into 1 treatment group

Sponsors and collaborators